Form 4 for EW Edwards Lifesciences
Accepted 2026-08-31 17:47:55 ET · period of report 2026-08-31 · accession 0001225208-26-007408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 17:47 | 2026-08-31 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | S - Sale | $91.06 | -544 | 14.9K | -4% | -$49.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-31 | S | D | 544 | $91.06 | 14,868.41 | D | — | — |